165 related articles for article (PubMed ID: 15364883)
1. Survivin is an independent prognostic marker for risk stratification of breast cancer patients.
Span PN; Sweep FC; Wiegerinck ET; Tjan-Heijnen VC; Manders P; Beex LV; de Kok JB
Clin Chem; 2004 Nov; 50(11):1986-93. PubMed ID: 15364883
[TBL] [Abstract][Full Text] [Related]
2. Survivin expression predicts early recurrence in early-stage breast cancer.
Yamashita S; Masuda Y; Kurizaki T; Haga Y; Murayama T; Ikei S; Kamei M; Takeno S; Kawahara K
Anticancer Res; 2007; 27(4C):2803-8. PubMed ID: 17695451
[TBL] [Abstract][Full Text] [Related]
3. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
4. Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?
Span PN; Tjan-Heijnen VC; Heuvel JJ; de Kok JB; Foekens JA; Sweep FC
Clin Chem; 2006 Sep; 52(9):1693-700. PubMed ID: 16873289
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M
Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870
[TBL] [Abstract][Full Text] [Related]
6. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
Yie SM; Luo B; Ye NY; Xie K; Ye SR
Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
[TBL] [Abstract][Full Text] [Related]
7. Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer.
Brennan DJ; Rexhepaj E; O'Brien SL; McSherry E; O'Connor DP; Fagan A; Culhane AC; Higgins DG; Jirstrom K; Millikan RC; Landberg G; Duffy MJ; Hewitt SM; Gallagher WM
Clin Cancer Res; 2008 May; 14(9):2681-9. PubMed ID: 18451232
[TBL] [Abstract][Full Text] [Related]
8. The expression and significance of survivin mRNA in urinary bladder carcinomas.
Wang H; Xi X; Kong X; Huang G; Ge G
J Cancer Res Clin Oncol; 2004 Aug; 130(8):487-90. PubMed ID: 15138808
[TBL] [Abstract][Full Text] [Related]
9. Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer.
O'Driscoll L; Linehan R; M Kennedy S; Cronin D; Purcell R; Glynn S; W McDermott E; D Hill A; J O'Higgins N; Parkinson M; Clynes M
Cancer Lett; 2003 Nov; 201(2):225-36. PubMed ID: 14607338
[TBL] [Abstract][Full Text] [Related]
10. Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival.
Kostadima L; Pentheroudakis G; Fountzilas G; Dimopoulos M; Pectasides D; Gogas H; Stropp U; Christodoulou C; Samantas E; Wirtz R; Hennig G; Bafaloukos D; Arapantoni P; Kalofonos H; Papakostas P; Economopoulos T; Bamias A; Pavlidis N
Breast Cancer Res Treat; 2006 Nov; 100(2):161-7. PubMed ID: 16823513
[TBL] [Abstract][Full Text] [Related]
11. Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients.
Hinnis AR; Luckett JC; Walker RA
Br J Cancer; 2007 Feb; 96(4):639-45. PubMed ID: 17285125
[TBL] [Abstract][Full Text] [Related]
12. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
[TBL] [Abstract][Full Text] [Related]
13. Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome.
Nassar A; Lawson D; Cotsonis G; Cohen C
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):113-20. PubMed ID: 18227733
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of survivin in breast cancer: meta-analysis.
Li Y; Ma X; Wu X; Liu X; Liu L
Breast J; 2014; 20(5):514-24. PubMed ID: 25041354
[TBL] [Abstract][Full Text] [Related]
15. A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.
Monzó M; Rosell R; Felip E; Astudillo J; Sánchez JJ; Maestre J; Martín C; Font A; Barnadas A; Abad A
J Clin Oncol; 1999 Jul; 17(7):2100-4. PubMed ID: 10561264
[TBL] [Abstract][Full Text] [Related]
16. Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas.
Schultz IJ; Kiemeney LA; Karthaus HF; Witjes JA; Willems JL; Swinkels DW; Gunnewiek JM; de Kok JB
Clin Chem; 2004 Aug; 50(8):1425-8. PubMed ID: 15277352
[No Abstract] [Full Text] [Related]
17. Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine.
Takeuchi H; Morton DL; Elashoff D; Hoon DS
Int J Cancer; 2005 Dec; 117(6):1032-8. PubMed ID: 15986442
[TBL] [Abstract][Full Text] [Related]
18. Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia.
Troeger A; Siepermann M; Escherich G; Meisel R; Willers R; Gudowius S; Moritz T; Laws HJ; Hanenberg H; Goebel U; Janka-Schaub GE; Mahotka C; Dilloo D
Haematologica; 2007 Aug; 92(8):1043-50. PubMed ID: 17640858
[TBL] [Abstract][Full Text] [Related]
19. Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients.
Ghadersohi A; Odunsi K; Zhang S; Azrak RG; Bundy BN; Manjili MH; Li F
Int J Cancer; 2008 Sep; 123(6):1376-84. PubMed ID: 18567002
[TBL] [Abstract][Full Text] [Related]
20. Cellular localisation of survivin: impact on the prognosis in colorectal cancer.
Ponnelle T; Chapusot C; Martin L; Bouvier AM; Plenchette S; Faivre J; Solary E; Piard F
J Cancer Res Clin Oncol; 2005 Aug; 131(8):504-10. PubMed ID: 15902487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
